MediWound Appoints Mr. Boaz Gur-Lavie as Chief Financial Officer
MediWound Ltd. - Ordinary Shares (MDWD)
Last mediwound ltd. - ordinary shares earnings: 2/25 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.mediwound.com/press-releases
Company Research
Source: GlobeNewswire
YAVNE, Israel, June 11, 2019 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced the appointment of Mr. Boaz Gur-Lavie as Chief Financial Officer, effective June 11, 2019. “We are pleased to have Boaz, a skilled and experienced financial management executive, join our dedicated and experienced leadership team,” said Sharon Malka, Chief Executive Officer of MediWound. “Boaz is an industry veteran with over a decade of extensive experience in M&As, IPOs, capital raises, investor and public relations, financial strategies and business development. We look forward to his valuable contributions as the Company advances the development of EscharEx® and works towards expanding the use of NexoBrid® in international markets.” Mr. Gur-Lavie stated, “I am thrilled to join the executive team at MediWound. MediWound is pioneering wound and burn ca
Show less
Read more
Impact Snapshot
Event Time:
MDWD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MDWD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDWD alerts
High impacting MediWound Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
MDWD
News
- MediWound: Gaining Traction [Seeking Alpha]Seeking Alpha
- MediWound Ltd. (NASDAQ: MDWD) had its price target raised by analysts at HC Wainwright from $5.50 to $23.00. They now have a "buy" rating on the stock.MarketBeat
- MediWound Ltd. (NASDAQ: MDWD) had its price target raised by analysts at Cowen Inc from $6.00 to $25.00.MarketBeat
- MediWound, Vericel gain on FDA approval of burn therapy [Seeking Alpha]Seeking Alpha
- MediWound Announces FDA Approval of NexoBrid® for the Treatment of Severe Thermal Burns in AdultsGlobeNewswire
MDWD
Earnings
- 11/15/22 - Miss
MDWD
Sec Filings
- 1/9/23 - Form 424B3
- 1/9/23 - Form 6-K
- 1/6/23 - Form 424B3
- MDWD's page on the SEC website